Sorrento Therapeutics, Inc. 4
4 · Sorrento Therapeutics, Inc. · Filed May 1, 2015
Insider Transaction Report
Form 4
Durand Mark
Director
Transactions
- Award
Stock Options
2015-04-29+120,000→ 145,000 totalExercise: $8.95Exp: 2025-04-29→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]30,000 of the original number of shares subject to this option shall vest and become exercisable on April 29, 2016 and 1/36 of the remaining options shall vest following each one month period of service thereafter, subject to the reporting person's continued service to the Company through each such vesting date.